Bioinformatics Platforms Market is expanding with Dassault Systemes SE acquiring Medidata Solutions to take leverage of Medidata’s cloud-based services to help the development of therapeutic innovations

 

Developed regions such as North America, typically the U.S. have shown the most promising signs when it comes to the bioinformatics platforms market. This is due to high adoption of new and advanced technology, which is complemented by continuous research and development activates in the region. Similarly, Asia Pacific is witnessing increased interest in the field of bioinformatics platforms due to the presence of skilled personnel.

Bioinformatics Platforms are collections of software applications designed to facilitate the analysis of biological information. The applications and their main functions are divided into three categories, these are Cloning Lines of Action, Gene Regulation, and Gene Function. They all can be combined into one application for better functionality. However, the applications vary depending on the needs of the user and the complexity of the job. Bioinformatics is widely used in research and development activities for either drug discovery, clinical diagnostics, or personalized medicine. Such thorough and highly advanced research activities require collaborative work, in order to leverage the expertise of both private and public organizations. Recently, in October 2020, The Walther Cancer Foundation invested around US$ 11 million to expand collaborative bioinformatics cancer research with Indiana University and Purdue University. Similarly, in January 2021, Curie-Cancer entered into a bioinformatics partnership deal with GenoSplice Technology for the application of cancer genomics. Such partnership and collaboration activities can stimulate growth of the bioinformatics platforms market.

Bioinformatics platforms are usually developed using applications written in C++. The source code is made human-readable to allow users to quickly analyze the data and manipulate it. Examples of these applications include the Illumina Genomics Platform, Gene Array Expression Profiling Software, and Genomics Data Migration Tool. In the recent past, the demand for nucleic acid and protein sequencing has increased massively. This is due to the fact that sequencing cost has reduced substantially, which is complemented by technological advancements. Such positive factors are also augmenting growth of the bioinformatics platforms market.

Recently, in June 2019, Dassault Systemes SE, a French software company, acquired Medidata Solutions, a provider for SaaS-based clinical development software, for US$ 5.8 billion with the aim to take leverage of Medidata’s cloud-based services to help the development of therapeutic innovations and clinical operations performance for pharmaceutical companies.

Good bioinformatics applications should be open source. This means the software should have a collaborative development plan and be collaboratively supported. Currently, there are many open-source applications available. To see what applications are currently out there check out the Bioinet website. Despite all these positive factors, the bioinformatics platforms market is hindered by a lack of well-defined standards and common data formats for the integration of data. Besides, the low availability of user-friendly tools at competitive prices can restrain growth of the bioinformatics platforms market.